Content about Alex Gorsky

April 29, 2013
J&J chairman pledges to restore U.S. OTC business, outlines growth opportunities overseas

Johnson & Johnson chairman and CEO Alex Gorsky last week told shareholders that its consumer healthcare business would reclaim its prominence in the U.S. marketplace at the company's annual shareholder meeting. But OTC growth will be greatest outside of the United States.

NEW BRUNSWICK, N.J. — Johnson & Johnson chairman and CEO Alex Gorsky last week told shareholders that its consumer healthcare business would reclaim its prominence in the U.S. marketplace at the company's annual shareholder meeting. But OTC growth will be greatest outside of the United States.

January 23, 2013
J&J chief: McNeil will work to reclaim marketshare this year

Johnson & Johnson expects to return about 75% of its OTC brands to the marketplace over the course of 2013, Alex Gorsky, J&J chairman and CEO told analysts.

NEW BRUNSWICK, N.J. — Johnson & Johnson expects to return about 75% of its OTC brands to the marketplace over the course of 2013, Alex Gorsky, J&J chairman and CEO told analysts Tuesday. "I’m very pleased with the progress that we’re making in that," he said. "We mentioned to you that the consent decree that we had designed in conjunction with the FDA was approved and reviewed in October, with very few comments. And given the breadth and scale of that agreement, we felt very good about that. We’ve had teams working hard since then.

December 3, 2012
Johnson & Johnson CEO Alex Gorsky to assume chairman title

Johnson & Johnson has announced that Alex Gorsky will assume, effective Dec. 28, the chairman title and additional leadership responsibilities for the global health care company.

NEW BRUNSWICK, N.J. — Johnson & Johnson has announced that Alex Gorsky will assume, effective Dec. 28, the chairman title and additional leadership responsibilities for the global health care company. 

Gorsky was appointed CEO of Johnson & Johnson in April 2012. Current chairman Bill Weldon will step down on Dec. 28 and plans to retire in the first quarter of 2013, after a brief transitional period.

February 22, 2012
J&J names successor to CEO

Johnson & Johnson on Tuesday named Alex Gorsky CEO of the company, effective April 26, the date of the company’s annual meeting of shareholders.

NEW BRUNSWICK, N.J. — Johnson & Johnson on Tuesday named Alex Gorsky CEO of the company, effective April 26, the date of the company’s annual meeting of shareholders. Gorsky also has been nominated for election to the board of directors at the meeting.

December 15, 2010
J&J's Alex Gorsky, Sheri McCoy named vice chairmen

Johnson & Johnson on Wednesday announced that Alex Gorsky, currently worldwide chairman of medical devices and diagnostics, and Sheri McCoy, currently worldwide chairman of pharmaceuticals, have been appointed vice chairmen of the executive committee, joining William Weldon, J&J chairman and CEO, in an expanded Office of the Chairman.

NEW BRUNSWICK, N.J. — Johnson & Johnson on Wednesday announced that Alex Gorsky, currently worldwide chairman of medical devices and diagnostics, and Sheri McCoy, currently worldwide chairman of pharmaceuticals, have been appointed vice chairmen of the executive committee, joining William Weldon, J&J chairman and CEO, in an expanded Office of the Chairman.

Both appointments are effective Jan. 3.